Chromosome 3p12.3-p14.2 and 3q26.2-q26.32 are genomic markers for prognosis of advanced nasopharyngeal carcinoma

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 10, 2009, Pages 2709-2716

  Sheu, Jim Jinn Chyuan ^a,b   Lee, Chia Huei ^c   Ko, Jenq Yuh ^d,e   Tsao, George S W ^g   Wu, Chung Chun ^c   Fang, Chih Yeu ^c   Tsai, Fuu Jen ^a,b   Hua, Chun Hung ^a   Chen, Chi Long ^f   Chen, Jen Yang ^c,e  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^g UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMTS9 GENE; ADFP GENE; ADVANCED CANCER; ARTICLE; CANCER CELL CULTURE; CHROMOSOME 3P; CHROMOSOME 3Q; CHROMOSOME DELETION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION; GPR160 GENE; HUMAN; HUMAN CELL; LRIG1 GENE; MICROARRAY ANALYSIS; MPDZ GENE; NASOPHARYNX CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; SKIL GENE; SURVIVAL RATE;

CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 3; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KAPLAN-MEIERS ESTIMATE; NASOPHARYNGEAL NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS;

EID: 70350091293     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-0349     Document Type: Article

References (50)

1. Muir CS. Nasopharyngeal carcinoma in non-Chinese populations with special reference to south-east Asia and Africa. Int J Cancer 1971;8:351-363
2. Simons MJ, Wee GB, Day NE, Morris PJ, Shanmugaratnam K, De-Thé GB. Immunogenetic aspects of nasopharyngeal carcinoma: I. Differences in HL-A antigen profiles between patients and control groups. Int J Cancer 1974;13:122-134
3. Chan AS, To KF, Lo KW, et al. High frequency of chromosome 3p deletion in histologically normal nasopharyngeal epithelia from southern Chinese. Cancer Res 2000;60:5365-5370
4. Feng BJ, Huang W, Shugart YY, et al. Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4. Nat Genet 2002;31:395-399 (Pubitemid 35154449)
5. Andersson-Anvret M, Forsby N, Klein G, Henle W. Relationship between the Epstein-Barr virus and undifferentiated nasopharyngeal carcinoma: correlated nucleic acid hybridization and histopathological examination. Int J Cancer 1977;20:486-494 (Pubitemid 8193335)
6. Yu MC, Mo CC, Chong WX, Yeh FS, Henderson BE. Preserved foods and nasopharyngeal carcinoma: a case-control study in Guangxi, China. Cancer Res 1988;48:1954-1959
7. Ward MH, Pan WH, Cheng YJ, et al. Dietary exposure to nitrite and nitrosamines and risk of nasopharyngeal carcinoma in Taiwan. Int J Cancer 2000;86:603-609
8. McDermott AL, Dutt SN, Watkinson JC. The aetiology of nasopharyngeal carcinoma. Clin Otolaryngol Allied Sci 2001;26:82-92.
9. Lung ML, Choi CV, Kong H, et al. Microsatellite allelotyping of chinese nasopharyngeal carcinomas. Anticancer Res 2001;21:3081-3084 (Pubitemid 33051179)
10. Shao JY, Huang XM, Yu XJ, et al. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma. Anticancer Res 2001;21:3021-3029 (Pubitemid 33051170)
11. Fang CY, Lee CH, Wu CC, et al. Recurrent chemical reactivations of EBV promotes genome instability and enhances tumor progression of nasopharyngeal carcinoma cells. Int J Cancer 2009;124:2016-2025
12. Lee CH, Fang CY, Sheu JJ, Chang Y, Takada K, Chen JY. Amplicons on chromosome 3 contain oncogenes induced by recurrent exposure to 12-O-tetradecanoylphorbol-13-acetate and sodium n-butyrate and Epstein-Barr virus reactivation in a nasopharyngeal carcinoma cell line. Cancer Genet Cytogenet 2008;185:1-10. (Pubitemid 352024393)
13. Chen YJ, Ko JY, Chen PJ, et al. Chromosomal aberrations in nasopharyngeal carcinoma analyzed by comparative genomic hybridization. Genes Chromosomes Cancer 1999;25:169-175 (Pubitemid 29226600)
14. Fan CS, Wong N, Leung SF, et al. Frequent c-myc and Int-2 overrepresentations in nasopharyngeal carcinoma. Hum Pathol 2000;31:169-178 (Pubitemid 30090645)
15. Chien G, Yuen PW, Kwong D, Kwong YL. Comparative genomic hybridization analysis of nasopharygeal carcinoma: consistent patterns of genetic aberrations and clinicopathological correlations. Cancer Genet Cytogenet 2001;126:63-67 (Pubitemid 32416529)
16. Yan J, Fang Y, Liang Q, Huang Y, Zeng Y. Novel chromosomal alterations detected in primary nasopharyngeal carcinoma by comparative genomic hybridization. Chin Med J (Engl) 2001;114:418-421 (Pubitemid 33611342)
17. Wong N, Hui AB, Fan B, et al. Molecular cytogenetic characterization of nasopharyngeal carcinoma cell lines and xenografts by comparative genomic hybridization and spectral karyotyping. Cancer Genet Cytogenet 2003;140:124-132 (Pubitemid 36349012)
18. Li X, Wang E, Zhao YD, et al. Chromosomal imbalances in nasopharyngeal carcinoma: a meta-analysis of comparative genomic hybridization results. J Transl Med 2006;4:4.
19. Hui AB, Lo KW, Leung SF, et al. Detection of recurrent chromosomal gains and losses in primary nasopharyngeal carcinoma by comparative genomic hybridisation. Int J Cancer 1999;82:498-503.
20. Huang Z, Desper R, Schaffer AA, Yin Z, Li X, Yao K. Construction of tree models for pathogenesis of nasopharyngeal carcinoma. Genes Chromosomes Cancer 2004;40:307-315 (Pubitemid 38902541)
21. Shih-Hsin Wu L. Construction of evolutionary tree models for nasopharyngeal carcinoma using comparative genomic hybridization data. Cancer Genet Cytogenet 2006;168:105-108 (Pubitemid 44026636)
22. Hui AB, Lo KW, Teo PM, To KF, Huang DP. Genome wide detection of oncogene amplifications in nasopharyngeal carcinoma by array based comparative genomic hybridization. Int J Oncol 2002;20:467-473
23. Guo X, Lui WO, Qian CN, et al. Identifying cancer-related genes in nasopharyngeal carcinoma cell lines using DNA and mRNA expression profiling analyses. Int J Oncol 2002;21:1197-1204
24. Or YY, Hui AB, Tam KY, Huang DP, Lo KW. Characterization of chromosome 3q and 12q amplicons in nasopharyngeal carcinoma cell lines. Int J Oncol 2005;26:49-56.
25. Lin CT, Wong CI, Chan WY, et al. Establishment and characterization of two nasopharyngeal carcinoma cell lines. Lab Invest 1990;62: 713-724 (Pubitemid 20213689)
26. Glaser R, Zhang HY, Yao KT, et al. Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas. Proc Natl Acad Sci U S A 1989;86:9524-9528 (Pubitemid 20010459)
27. Li HM, Man C, Jin Y, et al. Molecular and cytogenetic changes involved in the immortalization of nasopharyngeal epithelial cells by telomerase. Int J Cancer 2006;119:1567-1576 (Pubitemid 44258762)
28. Lee CH, Wu CC, Wu YN, Chiang HS. Gene copy number variations in Asian patients with congenital bilateral absence of the vas deferens. Hum Reprod 2009;24:748-755
29. Al-Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 1998;16:1310-1317 (Pubitemid 28175745)
30. Kutcher GJ, Fuks Z, Brenner H, et al. Three-dimensional photon treatment planning for carcinoma of the nasopharynx. Int J Radiat Oncol Biol Phys 1991;21:169-182
31. Roychowdhury DF, Tseng A, Jr., Fu KK, Weinburg V, Weidner N. New prognostic factors in nasopharyngeal carcinoma. Tumor angiogenesis and C-erbB2 expression. Cancer 1996;77:1419-1426
32. Schwab M. Oncogene amplification in solid tumors. Semin Cancer Biol 1999;9:319-325
33. Tjia WM, Sham JS, Hu L, Tai AL, Guan XY. Characterization of 3p, 5p, and 3q in two nasopharyngeal carcinoma cell lines, using regionspecific multiplex fluorescence in situ hybridization probes. Cancer Genet Cytogenet 2005;158:61-66 (Pubitemid 40354326)
34. Imoto I, Pimkhaokham A, Fukuda Y, et al. SNO is a probable target for gene amplification at 3q26 in squamous-cell carcinomas of the esophagus. Biochem Biophys Res Commun 2001;286:559-565 (Pubitemid 32912983)
35. Nomura N, Sasamoto S, Ishii S, Date T, Matsui M, Ishizaki R. Isolation of human cDNA clones of ski and the ski-related gene, sno. Nucleic Acids Res 1989;17:5489-5500 (Pubitemid 19187099)
36. Zhang F, Lundin M, Ristimaki A, et al. Ski-related novel protein N (SnoN), a negative controller of transforming growth factor-β signaling, is a prognostic marker in estrogen receptor-positive breast carcinomas. Cancer Res 2003;63:5005-5010 (Pubitemid 37022638)
37. Zhu Q, Krakowski AR, Dunham EE, et al. Dual role of SnoN in mammalian tumorigenesis. Mol Cell Biol 2007;27:324-339 (Pubitemid 46013254)
38. Takeda S, Kadowaki S, Haga T, Takaesu H, Mitaku S. Identification of G protein-coupled receptor genes from the human genome sequence. FEBS Lett 2002;520:97-101. (Pubitemid 34607281)
39. Conklin D, Yee DP, Millar R, Engelbrecht J, Vissing H. Mining of assembled expressed sequence tag (EST) data for protein families: application to the G protein-coupled receptor superfamily. Brief Bioinform 2000;1:93-99
40. Schlomm T, Luebke AM, Sultmann H, et al. Extraction and processing of high quality RNA from impalpable and macroscopically invisible prostate cancer for microarray gene expression analysis. Int J Oncol 2005;27:713-720
41. Trimeche M, Braham H, Ziadi S, Amara K, Hachana M, Korbi S. Investigation of allelic imbalances on chromosome 3p in nasopharyngeal carcinoma in Tunisia: high frequency of microsatellite instability in patients with early-onset of the disease. Oral Oncol 2008;44:775-783
42. Lo KW, Teo PM, Hui AB, et al. High resolution allelotype of microdissected primary nasopharyngeal carcinoma. Cancer Res 2000;60: 3348-3353
43. Sung NS, Zeng Y, Raab-Traub N. Alterations on chromosome 3 in endemic and nonendemic nasopharyngeal carcinoma. Int J Cancer 2000;86:244-250 (Pubitemid 30180820)
44. Chan AS, To KF, Lo KW, et al. Frequent chromosome 9p losses in histologically normal nasopharyngeal epithelia from southern Chinese. Int J Cancer 2002;102:300-303
45. Lo PH, Leung AC, Kwok CY, et al. Identification of a tumor suppressive critical region mapping to 3p14.2 in esophageal squamous cell carcinoma and studies of a candidate tumor suppressor gene, ADAMTS9. Oncogene 2007;26:148-157
46. Lung HL, Lo PH, Xie D, et al. Characterization of a novel epigenetically- silenced, growth-suppressive gene, ADAMTS9, and its association with lymph node metastases in nasopharyngeal carcinoma. Int J Cancer 2008;123:401-408 (Pubitemid 351842026)
47. Hedman H, Nilsson J, Guo D, Henriksson R. Is LRIG1 a tumour suppressor gene at chromosome 3p14.3? Acta Oncol 2002;41:352-354
48. Vineis P, Berwick M. The population dynamics of cancer: a Darwinian perspective. Int J Epidemiol 2006;35:1151-1159 (Pubitemid 44605529)
49. Breivik J. The evolutionary origin of genetic instability in cancer development. Semin Cancer Biol 2005;15:51-60. (Pubitemid 40018528)
50. Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NVBI gene expression and hybridization array data repository. Nucleic Acids Res 2002;30:207-210